Cooled ablation reduces pulmonary vein isolation time: results of a prospective randomised trial

書誌事項

公開日
2007-12-10
DOI
  • 10.1136/hrt.2007.125898
公開者
BMJ

この論文をさがす

説明

<jats:sec> <jats:title>Background:</jats:title> <jats:p>Currently, selection of the ablation catheter for pulmonary vein (PV) isolation is a matter of choice.</jats:p> </jats:sec> <jats:sec> <jats:title>Objective:</jats:title> <jats:p>To evaluate the efficiency of cooled ablation for PV isolation.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods:</jats:title> <jats:p>A prospective randomised trial was carried out comparing the time required to disconnect each targeted PV using cooled ablation (open irrigation at 15 ml/min, group A) or standard temperature-controlled 4 mm tip catheter ablation (group B). The ablation parameter limit settings were 45°C, 35 (5) W in group A, and 55°C, 35 (5) W in group B.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p>Thirty-six patients referred for a first atrial fibrillation (AF) ablation procedure were randomised to group A or group B (18 patients in each group). There were no significant differences in baseline characteristics between the groups. Bidirectional block was achieved in 61/61 PVs from group A (100%) and 59/61 PVs from group B (97%); p = NS. Time to PV disconnection was significantly shorter in group A than in group B (median (25th–75th centiles) 14 (5–28) min vs 19 (14–32) min, respectively; p<jats:italic> = </jats:italic>0.003). Five asymptomatic PV stenoses were identified by MRI, all in group B (p = 0.05). After 1-year minimum follow-up, AF recurrences were less frequently documented in patients treated with cooled ablation (6% vs 33%; p = 0.05).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion:</jats:title> <jats:p>Cooled ablation is more efficient than standard ablation in achieving PV isolation. Results obtained from this study also suggest a potential benefit of clinical efficacy and safety from cooled ablation, which should be further evaluated in larger clinical trials.</jats:p> </jats:sec>

収録刊行物

  • Heart

    Heart 95 (3), 203-209, 2007-12-10

    BMJ

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ